Other languages Teladoc Health, Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:02 2024-05-02 pm EDT			Pre-market 09:13:09 am
12.99 ^USD	+1.41%		13.48	+3.73%

Apr. 29	Truist Securities Cuts Teladoc's Price Target to $15 From $17, Maintains Hold Rating	MT
Apr. 26	UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating	MT

Teladoc Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25
Teladoc Health, Inc. Provides Earnings Guidance for the Second Quarter of 2024	Apr. 25
Teladoc Health, Inc. Announces Resignation of Richard J. Napolitano as Chief Accounting Officer, Effective May 3, 2024	Apr. 12
Teladoc Chief Executive Leaves, Chief Financial Officer Mala Murthy Named Acting CEO	Apr. 05
Teladoc Health, Inc. Announces Chief Executive Officer Changes	Apr. 05
Teladoc Health Seeks M&A	Mar. 13
Sector Update: Health Care Stocks Gain Late Afternoon	Mar. 07
Sector Update: Health Care Stocks Stronger in Afternoon Trading	Mar. 07
Teladoc Expands Obesity, Weight-Management Offering; Shares Rise	Mar. 07
Teladoc Health Insider Sold Shares Worth $266,354, According to a Recent SEC Filing	Mar. 05
Teladoc Health Insider Sold Shares Worth $433,854, According to a Recent SEC Filing	Mar. 05
Wall Street licht hoger gesloten	Feb. 21
Sector Update: Health Care Stocks Mixed in Late Afternoon	Feb. 21
Sector Update: Health Care Stocks Slipping Wednesday Afternoon	Feb. 21
Wall Street koerst af op lager slot	Feb. 21
LATE BRIEFING - Unternehmen und Märkte	Feb. 21
Vorsichtig aufwärts - HSBC belasten den Sektor	Feb. 21
Teladoc Shares Fall After Q4 Results, Guidance	Feb. 21
XETRA-SCHLUSS/DAX stabil über der 17.000er-Marke	Feb. 21
Vorsichtig aufwärts - HSBC belasten Sektor	Feb. 21

No results for this search